JBTM vs ECG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
JBTM
ECG
Investment Advisor Scores
ECG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | JBTM | ECG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 14.0252 | 10.8108 | ECG |
| PEG Ratio | 1.2201 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -0.7% | 40.3% | ECG |
| Earnings Growth | 6.3% | 61.3% | ECG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 24.4/100 | 54.2/100 | ECG |
| Profit Margin | 5.0% | 6.2% | ECG |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG SELL | HOLD | ECG |
Relative Price Performance (Last 90 Days)
Current Technical Phase
JBTM
NeutralMixed signals - no dominant trend phase, RSI 70
ECG
MarkdownPrice below a falling SMA50 (slope -10.3%), weak momentum, RSI 42
Fundamentals Snapshot
| Metric | JBTM | ECG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.5 | 12.7 |
| Trailing P/E | 34.7 | 14.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.4% |
| Gross Margin | 0.4% | 0.1% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 3.74 | 5.74 |
| Dividend Yield | 0.00% | — |